3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting researcher focus due to limited evidence suggesting distinct physiological characteristics. Present studies indicate that 3-HPC may display distinct responses on the brain system, possibly influencing to some of the unanticipated reactions related with PCP co